tiprankstipranks
Dermata Therapeutics price target lowered to $6 from $10 at Maxim
PremiumThe FlyDermata Therapeutics price target lowered to $6 from $10 at Maxim
5M ago
3 Penny Stocks to Watch Now, 8/6/24
Premium
Market News
3 Penny Stocks to Watch Now, 8/6/24
6M ago
Dermata achieves 50% enrollment in DMT310 Phase 3 STAR-1 clinical trial
Premium
The Fly
Dermata achieves 50% enrollment in DMT310 Phase 3 STAR-1 clinical trial
6M ago
Dermata Therapeutics Enhances Equity Plan and Approves Stock Split
PremiumCompany AnnouncementsDermata Therapeutics Enhances Equity Plan and Approves Stock Split
9M ago
Dermata Therapeutics: Unveiling Recent Financial Performance
Premium
Company Announcements
Dermata Therapeutics: Unveiling Recent Financial Performance
10M ago
Dermata Therapeutics up 93% at $1.18 after DMT410 Japan patent announcement
Premium
The Fly
Dermata Therapeutics up 93% at $1.18 after DMT410 Japan patent announcement
1y ago
Dermata announces FDA feedback on DMT310 Phase 3 development program
PremiumThe FlyDermata announces FDA feedback on DMT310 Phase 3 development program
2y ago
Dermata Therapeutics price target lowered to $4 from $16 at Maxim
Premium
The Fly
Dermata Therapeutics price target lowered to $4 from $16 at Maxim
2y ago
Dermata Therapeutics price target lowered to $1 from $4 at Maxim
Premium
The Fly
Dermata Therapeutics price target lowered to $1 from $4 at Maxim
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100